Literature DB >> 10451669

Transmission of hepatitis C within Australian prisons.

P S Haber1, S J Parsons, S E Harper, P A White, W D Rawlinson, A R Lloyd.   

Abstract

Transmission of hepatitis C virus (HCV) within prisons has long been suspected but has not been satisfactorily documented. We present four cases of HCV infection occurring during periods of continuous imprisonment. Each subject was HCV seronegative on entering prison and on repeat testing after 4-52 months in prison, but subsequently became seropositive. Two subjects gave a history of injecting drug use, and the most likely means of infection in the other two subjects were lacerations from barbers shears and lacerations arising from physical assault. There is an urgent need for detailed study of the incidence of HCV infection and the modes of transmission in prisons.

Entities:  

Mesh:

Year:  1999        PMID: 10451669     DOI: 10.5694/j.1326-5377.1999.tb123494.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  12 in total

1.  In search of the correct strategy for preventing the spread of HCV infection.

Authors:  M Montella; A Crispo; J Wynn-Bellezza
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

Review 2.  HIV/AIDS and other infectious diseases among correctional inmates: transmission, burden, and an appropriate response.

Authors:  Theodore M Hammett
Journal:  Am J Public Health       Date:  2006-01-31       Impact factor: 9.308

3.  Prisoners are at risk for hepatitis C transmission.

Authors:  Tony Butler; Azar Kariminia; Michael Levy; John Kaldor
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

4.  Incidence and risk for acute hepatitis C infection during imprisonment in Australia.

Authors:  Kate Dolan; Suzy Teutsch; Nicolas Scheuer; Michael Levy; William Rawlinson; John Kaldor; Andrew Lloyd; Paul Haber
Journal:  Eur J Epidemiol       Date:  2010-02       Impact factor: 8.082

5.  Prevalence of and risk factors for hepatitis C virus infection among STD clinic clientele in Miami, Florida.

Authors:  J S Weisbord; M J Trepka; G Zhang; I P Smith; T Brewer
Journal:  Sex Transm Infect       Date:  2003-02       Impact factor: 3.519

6.  Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study cohort, Australia.

Authors:  Jennifer A Gates; Jeffrey J Post; John M Kaldor; Yong Pan; Paul S Haber; Andrew R Lloyd; Kate A Dolan
Journal:  J Urban Health       Date:  2004-09       Impact factor: 3.671

7.  Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort.

Authors:  Suzy Teutsch; Fabio Luciani; Nicolas Scheuer; Luke McCredie; Parastu Hosseiny; William Rawlinson; John Kaldor; Gregory J Dore; Kate Dolan; Rosemary Ffrench; Andrew Lloyd; Paul Haber; Michael Levy
Journal:  BMC Public Health       Date:  2010-10-22       Impact factor: 3.295

8.  Drug use and opioid substitution treatment for prisoners.

Authors:  Heino Stöver; Ingo Ilja Michels
Journal:  Harm Reduct J       Date:  2010-07-19

Review 9.  Hepatitis C in European prisons: a call for an evidence-informed response.

Authors:  Amber Arain; Geert Robaeys; Heino Stöver
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

10.  Correlates of HIV, HBV, HCV and syphilis infections among prison inmates and officers in Ghana: A national multicenter study.

Authors:  Andrew A Adjei; Henry B Armah; Foster Gbagbo; William K Ampofo; Isaac Boamah; Clement Adu-Gyamfi; Isaac Asare; Ian F A Hesse; George Mensah
Journal:  BMC Infect Dis       Date:  2008-03-07       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.